bell potter research, page-4

Now is a fantastic time to buy more!

And if you are one of the burnt investors that bought at $7-$9 in the ramp up to the previous results Now is your chance to average down. Either that or sell - take the tax loss for end of year and buy back at these levels. Short term volatility - Mid $5.40's to $5.85.

I will be getting another 20,000 shares, so feel free to dump your stock :-)

Once PI 88 goes into commercialisation Bell Potters $14 valuation will pale in comparison to future share price. It will be the leading Liver cancer drug, based on the previous results.

Although lets hope the board and management have learnt from their previous two mistakes when raising capital.